Hong Kong stock movement: MicroPort Medbot-B surged 25.75%, with new product approvals and a surge in orders boosting stock price

Hong Kong Stock Movement MicroPort Medbot-B surged 25.75%. Based on recent key news: On December 29, MicroPort Medbot-B's self-developed bronchoscopic surgical robot "DuDao" received approval from the National Medical Products Administration. This product enters narrow lesion spaces in a non-invasive manner, which is significant for early-stage cancer lesions such as small lung nodules, driving the stock price up. Source: Economic Information Daily On December 28, MicroPort Medbot-B announced that the cumulative order volume of its core products in endoscopy, orthopedics, and vascular intervention has exceeded 230 units, with the global order volume of the Tumai endoscopic surgical robot ranking among the top two, indicating strong market demand. Source: Economic Information Daily On December 29, the Ministry of Industry and Information Technology established a standardization technical committee for humanoid robots and embodied intelligence to promote the application of robotic technology and enhance industry confidence. Source: Economic Information Daily Strong industry demand and significant policy support. Stocks with High Trading Volume in the Industry MicroPort Medical rose 7.89%, with a trading volume reaching HKD 334 million, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation. MicroPort Neuroscience rose 4.23%, with a trading volume reaching HKD 50.79 million, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation. Xianjian Technology had a trading volume of HKD 13.24 million. Based on recent news: On December 26, in terms of international expansion, the focus is on product R&D and sales progress in the European and American markets. Due to previous layouts of many companies in overseas channel mergers and production bases, the growth of the overseas market in the sector is expected to accelerate by 2026. This news boosted market confidence and drove the stock price up. On December 26, low-value consumable companies are accelerating the layout of overseas production bases to avoid high tariffs imposed by the U.S. and other regions on China. After the production of overseas bases by leading companies in 2026, they are expected to quickly regain the U.S. market share lost due to tariff policies, resulting in clear profit increments. This favorable expectation further drove the stock price up. On December 26, the centralized procurement of major in vitro diagnostic products has been implemented and is gradually being carried out. Although the overall market size has been compressed, domestic leading companies are continuously increasing their market share due to price and channel advantages, accelerating import substitution. The price impact brought by centralized procurement and the policy's suppression of testing volume will gradually dissipate, and the overall testing demand in the industry will still recover due to the aging trend and the increase in residents' testing penetration rate. This news has a positive impact on the stock price. The overall industry performance is good, and the internationalization strategy is progressing smoothly. Stocks with High Market Capitalization in the Industry Angelalign fell 0.08%. Based on recent news: On December 26, Angelalign held an MDR-CE certificate awarding ceremony in Shanghai. A delegation from TÜV Rheinland officially awarded the certificate to Angelalign, which enhanced the company's international recognition in the medical device field but did not significantly drive the stock price up Recently, there are no other important news. The competition in the medical device industry is intensifying and requires attention